baber/WOPTO huggingface dataset:
Patent PT-752877-E (PT)
Inventor: ANNEFJELLESTAD-PAULSEN
IPC: A61K38/095
Filed: 1995-03-09
Abstract: PCT No. PCT/SE95/00249 Sec. 371 Date Oct. 23, 1996 Sec. 102(e) Date Oct. 23, 1996 PCT Filed Mar. 9, 1995 PCT Pub. No. WO95/25534 PCT Pub. Date Sep. 28, 1995A solid pharmaceutical composition for oral administration of small and medium size peptides, particularly vasopressin, oxytocin, and their analogues, comprises said peptide, an enteric coat and a pharmaceutically acceptable carrier containing a buffering agent buffering at a pH of from 2 to 6, preferably at about pH 5. A method of manufacture of single doses of said peptide comprises mixing of the ingredients, forming the resulting mixture into spheres smaller than 2 mm, coating the spheres with an enteric coat which is readily soluble in gastric juice of pH 5.0 or higher but not at substantially lower pH, and filling the coated spheres in capsules or incorporating them into tablets, degradable in the stomach. Also disclosed is a method for oral administration to a patient of said single dose.
Patent PT-759993-E (PT)
Title: Dna sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1,4 glucans in plants, fungi and microorganisms
Inventor: WELSH THOMAS
IPC: C12N15/74
Filed: 1995-05-18
Abstract: DNA sequences coding for enzymes capable of facilitating the synthesis of linear □-1,4 glucans in plants, fungi and microorganisms. The invention relates to DNA sequences Coding for proteins having the enzymatic activity of an amylosucrase which allows the synthesis of linear □1,4 glucans from the substrate sucrose by bacteria, fungi and plants or in cell-free systems. The invention furthermore describes plasmids and bacteria containing these DNA sequences as well as processes for the production of plants and microorganisms capable of intracellularly or extracellularly expressing a polypeptide having amylosucrase activity. The invention furthermore relates to the production of pure fructose using proteins exhibiting the enzymatic activity of amylosucrase.
Patent PT-777734-E (PT)
Inventor: ARMELLE DELECLUSE
IPC: A01N63/50
Filed: 1995-08-24
Abstract: PCT No. PCT/FR95/01116 Sec. 371 Date May 13, 1997 Sec. 102(e) Date May 13, 1997 PCT Filed Aug. 24, 1995 PCT Pub. No. WO96/06171 PCT Pub. Date Feb. 29, 1996The invention relates to a sequence of nucleotides characterized in that it corresponds to the fragment HindIII of about 4.3 kb which can be obtained from the plasmid pJEG80.1 which has been deposited at the CNCM on Aug. 23, 1994 with the number I-1469 or capable of hybridizing in stringent conditions with said plasmid. It also relates to polypeptides resulting from the expression of said sequence and their utilization in toxic compositions against insects.
Patent PT-951390-E (PT)
Inventor: LYKKE KIRSTEN
IPC: C08J7/048
Filed: 1997-04-08
Abstract: PCT No. PCT/DK97/00149 Sec. 371 Date Oct. 8, 1998 Sec. 102(e) Date Oct. 8, 1998 PCT Filed Apr. 8, 1997 PCT Pub. No. WO97/38853 PCT Pub. Date Oct. 23, 1997A multilayered packaging material, in particular for flexible packagings, comprising when seen from the outer face to the inner face an outer, substantially transparent film (1) having a reverse print (2) on its inwardly facing surface; an intermediate layer (3, 4) connected to the printed surface of the outer film (1) and applied in fluid form to the inner, printed surface of the outer film (1); a metallization layer (5) connected to the inner face of the gas barrier layer (3) and an inner sealing medium layer (7), preferably in form of a polyolefine.
Patent PT-959888-E (PT)
Inventor: GEROLYMATOS PANAYOTIS NIKOLAS
IPC: A61K31/7056
Filed: 1997-08-08
Abstract: A new pharmaceutical composition is disclosed that comprises clioquinol, vitamin B12, and, optionally, pharmaceutical acceptable carriers and/or excipients. The use of the pharmaceutical composition removes or alleviates the side effects of clioquinol.
Patent PT-953068-E (PT)
Inventor: BRETSCHNEIDER ANNETT
IPC: C23D5/06
Filed: 1997-11-28
Abstract: Laminar body comprising a substrate, and applied thereto on one or both sides, at least one layer containing an enamel, wherein the layer or layers containing an enamel contains at least one phosphor.
Patent PT-901851-E (PT)
Inventor: SENK DIETER
IPC: B22D11/14
Filed: 1998-09-02
Abstract: A lateral face (11) is claimed for closing the casting space (6) of an installation for the continuous casting of metal strip. It has two internally cooled contra-rotating rolls (5, 5'), with horizontal axes, and the cylindrical lateral faces define a casting space (6). The width of the neck (7) determines the thickness of the strip. The lateral face (11) presents an active part (3) to rub against the sides (4) of the rolls (5, 5') during casting and faces the casting space (6). The dimensions of this active part (3) are such that its lower edge (12) is designed to be situated at a distance (d) equal to at least 1 mm above the neck (7) whilst the lateral face (7) is mounted on the casting installation. The continuous casting installation incorporating this lateral face is also claimed.
Patent PT-969891-E (PT)
Inventor: BACON RAYMOND JOHN
IPC: A61M15/00
Filed: 1998-03-16
Abstract: An aerosol dispenser which comprises of a body including a mouthpiece for inhalation of a substance. The substance is stored in a container, which has a depressable outlet, in a pressurised gaseous or liquid form. The outlet tube releases the dose when depressed towards the container. The depression acts on a depression spring; this is resisted by a pneumatic actuator when an actuator chamber is closed. On compression of the string the dispenser is cocked; when it is compressed for cocking there are means for the air to escape from the chamber. There is an opening into the chamber-this is controlled by a breath actuable valve. This comprises a valve inlet; a valve outlet that is connected to the port; these are connected by a flexible tube which can be in two positions-in the closed position it is kinked and in the open position it is un-kinked. There is a movable member (movably mounted in the body), that is connected to the valve inlet, which moves the tube to control the kinking of the tube. When the movable member is in its rest position the tube is kinked and when the movable member is moved towards the orifice on inhalation the tube is unkinked-this allows air to enter the chamber, the spring acts and releases the dose in the container. <IMAGE>
Patent PT-1029961-E (PT)
Inventor: SPADONI GIOVANNI
IPC: D06F29/00
Filed: 1999-11-23
Abstract: A combined washing machine (10), that comprises a washing apparatus defining a space (14) wherein there are contained a tub (18) with the associated rotary drum and access door (19), a motor (20) driving said drum, a pump (27), a mains water feeding and emptying hose (26) and a box (30) for the cleansing agents, characterized in that said washing apparatus is associated with a drying machine having in a space (16) a condenser or heat exchanger (42) with at least one coil, connected on the one side to said water hose (28) and on the other side to the washing hub (18) or the accumulation tank (56) integral with the machine (10) or external to the same, and one or more fans (38) for the creation of a flow of heated air through at least one or more heating elements (40), wherein said flow circulates in a duct (44) that incorporates said at least one coil of the heat exchanger (42) and develops around the perimeter of a perforated drum (32). <IMAGE>
Patent SG-102992-G (SG)
Title: Cleaning device for a liquid-sucking needle
IPC: G01N1/14
Filed: 1992-10-07
Abstract: A device is provided for cleaning a liquid sample taking needle, mounted fixedly on the frame of a sample taking apparatus, which device includes a mobile mechanism formed of a rinsing case (14) sliding over the sample taking needle (3) between a top position which it occupies during sample taking and a low position which it occupies during cleaning in which it covers the whole of the lower part of the needle, the end of this latter remaining withdrawn inside a cylindrical cleaning chamber (18) provided in the case through which the needle passes and at the lower part of which a depression is applied.
Patent IE-44330-L (IE)
Title: Dibenzoxazepine derivatives
IPC: A61K31/00
Filed: 1977-01-04
Abstract: The reaction of 1-(halo/cyano/sulfonyloxy)alkanoyl-2-(dibenzoxazepine-10-carbonyl)hydr azines with an amine affords the corresponding 1-(substituted amino)alkanoyl-2-(dibenzoxazepine-10-carbonyl)hydrazines which compounds are useful anti-inflammatory or anti-diarrheal agents.
[US4045442A]
Patent IE-44478-L (IE)
Title: Halogen cycle incandescent lamp
IPC: H01K1/32
Filed: 1977-01-12
Abstract: The invention relates to electric incandescent lamps having a gas fill containing halogen. The internal surface of hte lamp envelope and optionally also the exposed surface of internal components of the lamp are protected from attack by halogens including flourine by a continuos imperforate coating composed of a metal oxide resistant to halogen attack. In order to achieve the necessary degree of continuity of hte coating the oxide is formed in situ from a compound of the metal deposited as a solution on the surface. The preferred oxidee is alumina, the other oxides of polyvalent and transition metals, including metals of the lanthanide series may be used. The coatings are preferably formed from solutions of halides of the metals in polar organic solvents such as methanol. The invention prolongs the life of lamps provided with the protective coating and enable such resistant and possibly cheaper materials to be employed for certain lamp components.
[CA1097991A]
Patent IE-870075-L (IE)
Title: Microplastic structure as photomask in micro electronic¹sensors
IPC: G03F7/022
Filed: 1987-01-13
Abstract: Microplastic structures, thermally stable up to at least 200 deg.C are produced by (a) coating a substrate with a photosensitive compsn. contg. 40-99.9 wt.% crosslinkable polymer and 0.1-60 wt.% photoacid generator, (b) exposing the coating through one or more photomasks to light, (c) heating to 70-120 deg.C to crosslink the exposed coating(s), and (d) removing portions of the coating with an aq. base soln. Pref. the microplastic structure is in the positive or negative mode and the coating is exposed to a near UV light source. The compsn. pref. contains (i) 3-50 wt.% aminoplast, 90-40 wt.% of reactive H-contg. cpd. and 2-30 wt.% photoacid generator sensitive to near UV light or (ii) 50-95 wt.% phenoplast, 40-3 wt.% HCHO generating cpd. and 2-30 wt.% photoacid generator sensitive to near UV light, (iii) 95.99.9 wt.% acid-hardening resin, 0.1-5 wt.% photoacid generator sensitive to deep UV light at an exposure dosage of 10Mj/sq.cm.
Patent IE-44424-L (IE)
Title: 2-formylamino-phenylguanidines, anthelmintics.
IPC: C07C279/24
Filed: 1977-03-09
Abstract: N-(2-formamidophenyl)-N',N''-bis-carbonylguanidines bearing an optionally substituted phenoxy, phenylthio, phenylsulfinyl or phenylsulfonyl group in the 4- or 5-position of the 2-(formamido)-phenyl group are anthelminetic agents. The compounds, of which N-(2-formamido-4-phenylthiophenyl)-N',N''-bis-carbomethoxyguanidine is a typical example, are prepared through the reaction of isothiourea-S-alkyl ether and an appropriately substituted 2-aminoformanilide.
[US4127670A]
Patent IE-36325-L (IE)
Title: Prosthetic knee joint.
IPC: A61F2/38
Filed: 1972-04-25
Abstract: 1393085 Knee joint prosthesis NATIONAL RESEARCH DEVELOPMENT CORP 25 April 1972 [4 May 1971] 12919/71 Heading A5R A prosthetic knee-joint device comprises a femoral component Fig. 1, of a generally U- shaped channel member in which at least part of the outer surface 6, extending over one side wall 4, and part of the base 2, is of a convex curvature in the anterio-posterior direction; and a tibial component Fig. 6, including a platform member 10, having its upper surface 11, 12 concavely dished in a form generally complementary to the lower surface of the femoral component for mutual sliding and rolling engagement therewith. (Figure 9, not shown, illustrates the inter-engagement of modified femoral and tibial components). The remainder of the outer surface profile of the femoral component comprises a rectilinear part 7, extending from the curved part 6, to the remaining side wall 3, which has a curved profile of a smaller radius than the posterior side wall 4. The inner surface of the femoral component is adapted to be attached to the femur and may have a peg 5, of circular crosssection as an aid to fixation. The concavely dished surface of the platform of the tibial member comprises three parts; a central portion 11, having the same curvature as the surface 6, of the femoral component, and two substantially rectilinear edge parts 12, extending smoothly therefrom. A subsidiary platform 13 projects from the platform 10 and is used as an aid to fixation of the component to the tibia. The outer surface of the femoral component 6, 7 bears on the concave surface 11, 12 of the tibial component when in position at a joint and flexion is allowed between the surfaces 6 and 12 in the backward direction and is limited between surfaces 7 and 12 in the forward direction. In embodiments Figures 8, 9, 10, 11 (not shown) a peg (20) on the tibial component engages with a groove (21) on the femoral component, slots (22, 23) in both components provide clearance for ligaments, and an inturned edge (24) assists in fixation of the femoral component.
[GB1393085A]
Patent IE-890864-L (IE)
Title: Heparin-binding proteins
IPC: A61P43/00
Filed: 1989-03-20
Abstract: A heparin-binding protein (HBP) which has, in glycosylated state, an apparent molecular weight of about 28 kDa, determined by SDS-PAGE under reducing conditions, and exhibits angiogenic properties in vivo.
[WO8908666A1]
Patent IE-33181-L (IE)
Title: Imidazolidino-quiazolines.
IPC: C07D487/04
Filed: 1969-06-27
Abstract: 1,273,764. Bronchodilators. SCHERICO Ltd. 27 June, 1969 [1 July, 1968], No. 32670/ 69. Heading A5B. [Also in Division C2] Pharmaceutical compositions having bronchodilating activity comprise, as active ingredient, at least one imidazolidino-quinazoline of the general formula: or a corresponding 3a, 4- or 10, 10a-dihydro compound, respectively, wherein R 1 is a hydrogen atom, a saturated or unsaturated hydrocarbyl radical having up to six carbon atoms or a pyridyl-alkyl, phenyl, phenyl-C 1-6 alkyl, hydroxy-C 1-6 alkyl or acyloxy-C 1-6 alkyl group, R 2 is a hydrogen atom or a C 1-6 alkyl group, R 3 is a hydrogen atom or a C 1-6 alkyl, phenyl, phenyl-C 1-6 alkyl or haloalkyl group or a heterocyclic radical, or R 2 and R 3 , taken together with the adjacent carbon atom, form a cycloalkylidene group or a 5- or 6-membered nitrogen-containing heterocyclic group, and X, Y and Z are each a hydrogen or halogen atom or a C 1-6 alkylthio, C 1-6 alkylsulphinyl, C 1-6 alkyl sulphonyl, trifluoromethyl, C 1-6 alkyl, nitro, hydroxy or C 1-6 alkoxy group, or X and Y together form a fused benzene ring, the phenyl groups in the definitions of R 1 and R 3 being unsubstituted or substituted by C 1-6 alkylthio, C 1-6 alkylsulphinyl, C 1-6 alkylsulphonyl, trifluoromethyl, C 1-6 alkyl, nitro, hydroxy or C 1-6 alkoxy groups or halogen atoms, or a pharmaceutically acceptable acid addition or quaternary ammonium salt thereof, together with at least one of the following: (i) a further bronchodilating agent and/or an antihistamine; (ii) a pharmaceutical carrier or excipient. The further bronchodilating agent may be aminophylline or isoproterenol. The compositions may be administered orally, parenterally or rectally as tablets, capsules, suppositories, dragees, lozenges, syrups, elixirs, emulsions, suspensions, aerosol sprays and injectable preparations.
[GB1273764A]
Patent IE-36949-L (IE)
Title: Synthetic plastics pipes
IPC: B29C48/32
Filed: 1972-07-05
Abstract: 1395962 Extruding partitioned plastics tubes W HEGLER 5 July 1972 [31 July 1971] 31517/72 Heading B5A [Also in Divisions F2 and C1] A plastics tube is extruded having an integral partitioning wall means which extends across the tube interior between the tube wall and follows a helical path axially of the tube, to divide all of the bore of the tube into separate helical passages. The tube wall may be helically corrugated, and the partitioning wall means may be of the hand 24 shown in Fig. 3, dividing the tube diametrically, may be of the opposite hand (25), Fig. 4 (not shown), dividing the tube into three equal segments, or may be of alternating hand 26 and divide the tube into four segments as shown in Fig. 5, The tubes may be coiled around a cylinder which is rotated to scoop air and effluent or sewage through the tube whilst agitated for biological treatment in contact with a biological "lawn" which develops inside the tube, and which treatment is enhanced by additional agitation provided by the tube corrugations. Alternatively, the effluent may be passed through bundles of uncoiled tubes by gravity, or pressure. The tubes may alternatively be used for the conveyance of solid suspensions without settlement of the solids. The tube is extruded from an orifice, Fig. 1 defined between a stationary external die 1, and a mandrel 2 which rotates to define the helical path of a partition wall 16 which is formed by slots 13 extending radially inwardly of the mandrel 2 and to which plastics material is delivered by upstream mandrel grooves 14. The extruding tube is engaged between moving opposed chains of co-operating mould halves 17 which form corrugations, upon application of vacuum via mould passages 21 communicating with stationary vacuum sources 23, the formation of the corrugations being facilitated by communication of the tube interior with atmosphere, by passages 18 through the mandrel 1. The mandrel 1 is mounted for rotation within stationary spider 10 to which it is sealed by a flexibly deformable sleeve 12, urged against the mandrel by the pressure of the plastics 8 within the die head. The 1 is rotated by external sprockets 6 the drive of which is transmitted, by chains passing through the spider arms, to mandrel sprockets 4 housed within a spider cavity containing lubricant and in which a bearing 3 for the mandrel 4 is housed. The mandrel air passages 18 communicate with atmosphere through the spider arms, via an outlet 19 from the mandrel which is located above the level of lubricant 11 in the cavity and to which the ingress of lubricant is prevented by a surrounding drip shield.
[GB1395962A]
Patent FI-823837-L (FI)
Inventor: MUGGLI JYRG
IPC: G08B29/00
Filed: 1982-11-09
Abstract: A smoke detector is disclosed having a radiation source operated in a pulsed mode. Externally of a direct radiation region of the radiation source there is arranged a radiation receiver which, in the presence of smoke or other particles emanating from a combustion process and located in the radiation region, is impinged by scattered radiation and delivers an output signal to an evaluation circuit. The evaluation circuit contains switching elements which, when the number of source output signals or pulses exceeds a predetermined threshold value for the number of source output pulses, delivers an alarm signal. Near to the radiation receiver there is arranged a reference cell in the direct radiation beam of the radiation source, this reference cell controlling the emission of radiation by the radiation source. Further, there is provided circuitry which, in the presence of a slow change in the amplitude of the receiver output pulse, adjusts an amplitude threshold value set for the amplitude of the receiver output pulse at a rate corresponding to a time-constant of more than one minute. Consequently, there is obtained an output signal of the radiation receiver which is dependent upon the smoke density and which is independent of the contamination or soiling of the smoke detector.
Patent FI-823873-L (FI)
Inventor: ERICSON STURE
IPC: E03C1/295
Filed: 1982-11-11
Abstract: The present invention relates to a waste water outlet sanitary plant comprising a siphon forming a water seal (6) to which is connected a waste pipe (3) for connection with sewers and in which an automatic air valve device (11) and a siphon are combined in one single apparatus so that their functions are complementary. A cylindrical body (1) having a permanent water seal (6) and in which a pipe or equivalent connected to an apparatus such as a sink, a basin or waste outlet is dipping, is combined with an automatic air valve (11) with peripheral air entry. Outside the pipe dipping into the water seal there is an internal partition (24) which creates a separation between the water seal (6) and the automatic valve device (11) situated at the upper part of the cylindrical body (1) protecting the said valve (11) against a raising or splashing of the liquid situated in the water seal (6).
Patent FI-844129-L (FI)
Inventor: GIROUD-ABEL BRUNO
IPC: C08K5/00
Filed: 1984-10-19
Abstract: The polyamides are fireproofed and, e.g., phosphine-inhibited, by formulating red phosphorus and at least one lanthanide or yttrium compound therewith.
Patent IE-871069-L (IE)
Title: Anti-dementia agents.
IPC: C07H19/167
Filed: 1987-04-24
Abstract: An anti-dementia agent comprising as an active ingredient an adenosine derivative io disclosed. The antidementia agent is useful in the therapy of various types of dementia, especially senile dementia. Examples of the adenosine derivative include L-N<6>-phenylisopropyladenosine, 2-chloroadenosine. N<6>-cyclohexyladenosine, adenosine-5 min -(N-cyclopropyl)carboxamide.
Patent IE-881366-L (IE)
Title: Dipyridoxyl phosphate NMRI contrast agents
IPC: C07F13/00
Filed: 1988-05-06
Abstract: N,N min -bis-(pyridoxal-5-phosphate)-alkylenediamine-N,N min -diacetic acids, N,N min -bis-(pyridoxal-5-phosphate)-1,2-cycloalkylenediamine N,N min -diacetic acids, and N,N min -bis-(pyridoxal-5-phosphate)-1,2-arylenediamine-N,N min -diacetic acids, the corresponding monophosphate compounds and monoacetic acid compounds, and their salts and esters form stable, highly soluble chelates with paramagnetic metal ions, and are highly effective NMRI contrast agents. Preferred contrast agents are paramagnetic ion chelates of N,N min -bis-(pyridoxal-5-phosphate)ethylene diamine-N,N min -diacetic acid, N,N min -bis-(pyridoxal-5-phosphate)trans-1,2-cyclohexylenediamine-N,N min -diac etic acid, N,N min -bis-(pyridoxal-5-phosphate)trans-1,2-arylenediamine-N,N min -diacetic acid, and the soluble calcium salts thereof. Novel intermediates for forming these compounds are N,N min -bis(pyridoxal-5-phosphate)alkylenediimines, N,N min -bis(pyridoxal-5-phosphate)alkylenediamines, N,N min -bis(pyridoxal-5-phosphate)-1,2-cycloalkylenediimines, N,N min -bis(pyridoxal-5-phosphate)-1,2-cycloalkylenediamines, N,N min -bis(pyridoxal-5-phosphate)-1,2-arylenediamines, and the corresponding monophosphate compounds.
[EP0290047A2]
Patent IE-851638-L (IE)
Title: Wall mounted exercise unit
IPC: A63B23/00
Filed: 1985-06-28
Abstract: A wall mounted exercise unit, particularly adapted for home or personal use. The exercise unit is readily stored in a folded position and includes an exercise bench which may be pivoted at an intermediate location to provide a wide range of exercise positions. Various accessory units may be readily incorporated into the exercise unit. The exercise unit may include a carriage assembly which allows the user to selectively exert a lifting force equal to either the full amount of weight set on the exercise unit, or only a portion of the weight set.
[US4634127A]
Patent IE-44067-L (IE)
Title: 1,5 inter-(2,5-thienylene)-heptanorprostaglandins.
IPC: C07D307/935
Filed: 1976-07-30
Abstract: 5-(2-Carboxythiophen-5-yl)-16-aryloxy- alpha -tetranor- omega -tetranorprostaglandins and intermediates useful in their preparation are disclosed. The novel prostaglandins of this invention have been found to have activity profiles comparable to the parent prostaglandins but they exhibit a greater tissue specificity of action.
[US4065472A]
Patent IE-901706-L (IE)
Title: Osmotic dosage form
IPC: A61K31/57
Filed: 1990-05-11
Abstract: An osmotic device is disclosed comprising an estrogenic and a progestogenic steroid that are delivered as a contraceptive pair for fertility regulation in a female.